Status:
NOT_YET_RECRUITING
Pioneering Advancements in Cardiocerebrovascular Interactions in the Asia pacFIC - Patent Foramen Ovale Study
Lead Sponsor:
National University Hospital, Singapore
Conditions:
Ischemic Stroke
Patent Foramen Ovale
Eligibility:
All Genders
18+ years
Brief Summary
A registry of patients from the Asia-Pacific region with PFO and ischemic stroke, designed to study the characteristics, investigations, treatment and outcomes using real-world data.
Detailed Description
This is an observational, multi-center, non-randomized real-world registry including ischemic stroke and/or transient ischemic attack patients with PFO in the Asia Pacific region. The primary objectiv...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Subject has experienced acute ischemic stroke or transient ischemic attack
- Subject is screened with presence of PFO (right-to-left shunt) on appropriate cardiac imaging (transthoracic echocardiography and/or transesophageal echocardiography) or transcranial Doppler bubble study
- Age ≥18 years
- Exclusion Criteria
- Stroke mimics, haemorrhagic stroke or cerebral venous thrombosis
- Subjects with less than 3 months of follow up
Exclusion
Key Trial Info
Start Date :
July 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06983795
Start Date
July 1 2025
End Date
December 1 2030
Last Update
May 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Hospital
Singapore, Singapore